Form 4 for CORZ Core Scientific, Inc./tx
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0000905148-25-000867 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | CORZ | Becker Todd A | Dir | S - Sale | $10.75 | -134.2K | 195.7K | -41% | -$1.44M |
| DM | 2025-03-05 | 2025-03-03+ | CORZ | Becker Todd A | Dir | S - Sale | $7.73 | -19.7K | 5,069 | -80% | -$152.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | S | D | 134,250 | $10.75 | 195,687 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.50 to $10.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| 2 | Derivative | Tranche 2 Warrants | 2025-03-04 | S | D | 5,069 | $9.89 | 0 | D | $0.01 · — to 2029-01-23 | 5,069 Common Stock | (F6) The price reported is a weighted average price. These Tranche 2 Warrants were sold in multiple transactions at prices ranging from $9.7867 to $9.955, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 2 Warrants sold at each separate price within such range. (F4) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of the Issuer's common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days, subject to certain adjustments. The Tranche 2 Warrants became exercisable at the option of the registered holders on July 11, 2024. |
| 3 | Derivative | Tranche 1 Warrants | 2025-03-03 | S | D | 10,763 | $5.57 | 0 | D | $6.81 · 2024-01-23 to 2027-01-23 | 10,763 Common Stock | (F3) The price reported is a weighted average price. These Tranche 1 Warrants were sold in multiple transactions at prices ranging from $5.56 to $5.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 1 Warrants sold at each separate price within such range. (F2) Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $6.81 per share, subject to certain adjustments. |
| 4 | Derivative | Tranche 2 Warrants | 2025-03-03 | S | D | 3,900 | $10.86 | 5,069 | D | $0.01 · — to 2029-01-23 | 3,900 Common Stock | (F5) The price reported is a weighted average price. These Tranche 2 Warrants were sold in multiple transactions at prices ranging from $10.75 to $10.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 2 Warrants sold at each separate price within such range. (F4) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of the Issuer's common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days, subject to certain adjustments. The Tranche 2 Warrants became exercisable at the option of the registered holders on July 11, 2024. |